Manning & Napier Group's EW Position Overview
Manning & Napier Group (via Manning & Napier Advisors LLC) currently holds 23 shares of Edwards Lifesciences Corporation (EW) worth $1,983, representing 0.00% of the portfolio. First purchased in 2025-Q4, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Manning & Napier Group has initiated a new position in EW, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Manning & Napier Group's Edwards Lifesciences Corporation (EW) Holding Value Over Time
Track share changes against reported price movement
Quarterly Edwards Lifesciences Corporation (EW) Trades by Manning & Napier Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +23 | New Buy | 23 | $86.22 |
Manning & Napier Group's Edwards Lifesciences Corporation Investment FAQs
Manning & Napier Group first purchased Edwards Lifesciences Corporation (EW) in Q4 2025, acquiring 23 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Manning & Napier Group has held Edwards Lifesciences Corporation (EW) for 1 quarters since Q4 2025.
Manning & Napier Group's largest addition to Edwards Lifesciences Corporation (EW) was in Q4 2025, adding 23 shares worth $1,983.
According to the latest 13F filing for Q4 2025, Manning & Napier Group's firm, Manning & Napier Advisors LLC, owns 23 shares of Edwards Lifesciences Corporation (EW), valued at approximately $1,983.
As of the Q4 2025 filing, Edwards Lifesciences Corporation (EW) represents approximately 0.00% of Manning & Napier Group's publicly disclosed stock portfolio, making it one of their key holdings.
Manning & Napier Group's peak holding in Edwards Lifesciences Corporation (EW) was 23 shares, as reported at the end of Q4 2025.